Home › Funds › Vanguard Group › PLRX

Vanguard Group position in PLRX

PLIANT THERAPEUTICS INC · Health Care

Latest position (Q4 2025)2.82M sh
Reported value held$3.44M
Portfolio Weight0.00%
First reportedQ1 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q1 2021 1.10M $43.37M New
Q2 2021 1.27M $37.03M Add
Q3 2021 1.42M $23.95M Add
Q4 2021 1.22M $16.45M Reduce
Q1 2022 1.23M $8.64M Add
Q2 2022 1.05M $8.43M Reduce
Q3 2022 1.60M $33.41M Add
Q4 2022 1.95M $37.68M Add
Q1 2023 2.37M $63.11M Add
Q2 2023 2.78M $50.32M Add
Q3 2023 2.95M $51.07M Add
Q4 2023 3.07M $55.52M Add
Q1 2024 3.48M $51.83M Add
Q2 2024 3.44M $36.95M Reduce
Q3 2024 3.53M $39.53M Add
Q4 2024 3.23M $42.52M Reduce
Q1 2025 3.33M $4.50M Add
Q2 2025 3.00M $3.48M Reduce
Q3 2025 2.78M $4.11M Reduce
Q4 2025 2.82M $3.44M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding PLRX

All PLRX fund holders →